Disclosed are pharmaceutical compositions comprising immediate release and sustained release formulations of 5 -aminosalicylic acid, or a pharmaceutically acceptable salt or ester thereof, and/or N-acetylcysteine, or a pharmaceutically acceptable salt or ester thereof, for release in the lower gastrointestinal tract.